Le Lézard
Classified in: Health, Science and technology
Subject: PDT

Seacoast Laboratory Data Systems Announces new KPI Report Dashboard for SurroundLab AR


Ready for a clear and comprehensive view into your critical business metrics? Discover the new cutting-edge Data Insights web report dashboard for SurroundLab AR. Explore the easy-to-use dashboard which includes industry standard Key Performance Indicators providing valuable insights into your business performance.

DOVER, N.H., April 24, 2024 /PRNewswire-PRWeb/ -- Seacoast Laboratory Data Systems, a nationwide leader in providing customizable LIS and AR software solutions for commercial and hospital outreach laboratories, recently announced the addition of SurroundLabTM Data Insights for SurroundLabTM AR.

SurroundLabTM Data Insights, your window to key business metrics

"In today's laboratory, the amount of data available for analysis can be overwhelming; Seacoast's objective is to offer an easily accessible and transparent view of Key Performance Indicators, enabling managers to swiftly evaluate business health and promptly pinpoint areas of concern." commented John Herring, President and CEO of Seacoast Laboratory Data Systems Inc.

Providing a clear and comprehensive view into critical business metrics, SurroundLabTM Data Insights web report dashboard was designed with the busy lab professional in mind.

Pre-configured with several industry standard Key Performance Indicator reports, the report dashboard will immediately provide a deeper understanding of how your business is performing.

And with data export and online graphing options, you can quickly and easily view and manage your KPI data in whatever format bests suits your work style.

About Us

Since 1986, Seacoast has built a proven track record of providing top-notch, tailor-made software solutions to the Laboratory industry. Our Seacoast Suite of Products for the clinical lab, including our flagship LIS and RCM solutions, are specifically designed for clinical labs. By seamlessly integrating and automating various processes, our systems empower you to achieve exceptional outcomes while minimizing the demands on personnel. Additionally, our cloud-based alternative ensures secure access to critical business systems, providing peace of mind and reducing your IT expenses.

Increase your operational efficiency by reducing your IT footprint while maximizing your staffing resources. Seamlessly adapt to shifts in the market and regulatory landscape while focusing on shaping your business according to your vision.

Visit us today to learn more! https://www.sldsi.com/report-dashboard

Media Contact

Lisa M. Turgeon, Seacoast Laboratory Data Systems, Inc., 1 603-514-2158, [email protected], https://www.sldsi.com/

SOURCE Seacoast Laboratory Data Systems, Inc.


These press releases may also interest you

at 03:05
Kindeva Drug Delivery Invests in Second Manufacturing Line for Greener Inhalers at UK Manufacturing Site
Kindeva Drug Delivery (Kindeva), a global leader in drug-device combination products, today announced its investment in a second manufacturing line for the production of pressurized metered-dose inhaler (pMDI) products containing low-GWP (Global...

at 03:05
Oregon Therapeutics & Lantern Pharma Launch Strategic AI Collaboration to Optimize Development of First-In-Class Drug Candidate XCE853 ? A Potent Inhibitor of Cancer Metabolism
Lantern Pharma Inc. , a leading artificial intelligence (AI) oncology drug discovery and development company, today announced a strategic AI-driven collaboration with French biotechnology company, Oregon Therapeutics to optimize the development of...

at 03:00
Red light therapy for repairing spinal cord injury passes milestone
Patients with spinal cord injury (SCI) could benefit from future treatment to repair nerve connections using red and near-infrared light....

at 03:00
World Lupus Federation Global Survey Finds 91% of People with Lupus Report Using Oral Steroids to Treat Lupus
A recent global survey conducted by the World Lupus Federation reported that 91% of survey respondents were taking or have taken oral steroids to treat their lupus. Over 7,700 people living with lupus from more than 100 countries participated in the...

at 02:11
Calliditas announces positive topline results of Phase 2 head and neck cancer trial with lead NOX inhibitor candidate, setanaxib
Calliditas Therapeutics AB ("Calliditas") today announced data from the proof-of-concept Phase 2 trial evaluating setanaxib, its lead NOX enzyme inhibitor, in combination with pembrolizumab, in patients with squamous cell carcinoma of the head and...

at 00:01
Novo Nordisk Foundation, Wellcome, and the Gates Foundation Join Forces to Accelerate Global Health Equity and Impact
The Novo Nordisk Foundation, Wellcome, and the Bill & Melinda Gates Foundation announced a new partnership to support critical scientific research and development (R&D) for global health. The partnership is focused on supporting science and...

More news about Health...


News published on and distributed by: